Articles

3PB Barristers’ Matthew Cannings, who heads the Property & Estates team reviews Trecarrell House decision on landlords’ eviction rights and gas safety certificates.

3PB construction and commercial/insolvency barrister John Jessup predicted on Tuesday June 9 at the 3PB construction law webinar that the Supreme Court may push open the door left slightly ajar by Lord Justice Coulson at the Court of Appeal in the case of Bresco v Lonsdale [2019] EWCA Civ 27.

3PB’s pupil barrister Mariya Peykova has reviewed the use of police tactics to disperse protestors and the fine line between protesting and anti social behaviour.

3PB's Grace Nicholls provides a case summary of Valerie Tindall (2) Valerie Tindall (as administrator of the estate of Malcolm Tindall (deceased) v (1) Chief Constable of Thames Valley (2) Buckinghamshire County Council [2020] EWHC 837 (QB).

3PB's Naomi Webber provides a case summary of Paul & Anor v Royal Wolverhampton NHS Trust [2020] EWHC 1415 (QB).

3PB's Charles Fulton provides a case summary of Deborah Barlow v Wigan Metropolitan Borough Council [2020 EWCA Civ 696]

3PB's Sharan Sanghera analyses the provision of PPE during the Coronavirus pandemic.

Catherine Purdy reviews remote hearings.

3PB’s Public and Regulatory Law barrister Matthew Wyard has reviewed the law regulating novel food products in the UK.

3PB’s specialist commercial law barristers David Parratt QC and Rebecca Farrell review the cost consequences for lawyers and their clients of a refusal to engage in ADR.

The article includes a recent case law review which demonstrates a particular trend whereby Courts will examine closely the actions of the parties in relation to offers of ADR as to whether they are ‘reasonable’ or not. Even the failure to respond to a Part 36 Offer alongside an offer to mediate, can of itself potentially signify an unreasonable refusal to engage with ADR.

3PB’s Public and Regulatory barrister Matthew Wyard has provided an overview of the MHRA’s Market Authorisation process for bringing new products to market in the UK. Designed for the pharmaceutical industry and those advising them, this article looks at the different types of authorisation available and the process for approving medicines in the UK.

3PB’s Public and Regulatory Law barrister Matthew Wyard has provided an update on UK tobacco law in light of Article 7 of the EU Tobacco Productive Directive.